Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1receptor modulator, in the first-in-human study
Author:
Affiliation:
1. Department of Clinical Pharmacology; Actelion Pharmaceuticals Ltd; Allschwil Switzerland
2. College of Pharmacy; Department of Pharmaceutics; University of Florida; Gainesville FL USA
3. Clinical Research Services Kiel GmbH; D-24105 Kiel Germany
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12129/fullpdf
Reference37 articles.
1. Molecular determinants controlling homeostatic recirculation and tissue-specific trafficking of lymphocytes;Tanaka;Int Arch Allergy Immunol,2004
2. Homing of antibody secreting cells;Cyster;Immunol Rev,2003
3. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs;Cyster;Annu Rev Immunol,2005
4. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology;Brinkmann;Pharmacol Ther,2007
5. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients;Schwab;Science,2005
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation;Cellular Immunology;2024-07
2. Icanbelimod (CBP-307), a next-generation Sphingosine-1-phosphate receptor modulator, in healthy men: pharmacokinetics, pharmacodynamics, safety, and tolerability in a randomized trial in Australia;Frontiers in Immunology;2024-06-17
3. Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study;Journal of Women's Health;2024-04-01
4. Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study;Clinical Pharmacology in Drug Development;2024-03-05
5. Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults;Clinical Pharmacology in Drug Development;2024-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3